The Food and Drug Administration (FDA) warned consumers not to purchase or use a large number of tainted weight loss products, Dec. 22. The warning alerted consumers against the consumption of more than 25 weight loss products, because the may contain harmful ingredients.
Weight Loss Products May Contain Harmful Ingredients
According to the FDA, some of the products may contain "undeclared active pharmaceutical ingredients," including:
- Sibutramine, a controlled substance
- Rimonabant, a drug that is not approved for marketing in the U.S.
- Phenytoin, an anti-seizure medication
- Phenolphtheleinm, a solution used for chemical experiments, thought to cause cancer
According to the FDA, the majority of the weight loss products are marketed as dietary supplements and can be purchased online and in some retail stores. In the alert, the FDA advises consumers who are using any of the products to stop use and consult their physicians immediately.
Serious Potential Side Effects
There are several serious side effects attributed to the so-called weight loss products, including:
- Seizures
- High blood pressure
- Tachycardia
- Palpitations
- Heart attack
- Stroke
In an effort to protect consumers against these dangerous products and drugs, the FDA encourages all American consumers to consult their physicians before starting any type of weight loss plan.
More Than 25 Defective Products Listed
The FDA warns against more than 25 different tainted weight loss products. Some of the more known products include:
- Fatloss Slimming
- 7 Day Herbal Slim
- Perfect Slim
- ProSlim Plus
- Superslim
- Venom Hyperdrive 3.0
- 2 Day Diet
- 8 Factor Diet
- Royal Slimming Formula
- Slimtech
- TripleSlim
To view the full list of dangerous drugs and products, visit the FDA’s web site.
(Source: FDA MedWatch)
Have you or someone you love been harmed by a defective drug or product? If so, contact us immediately to schedule a private consultation with an experienced defective drug attorney who will help you fight to recover compensation for your losses.
